Ivabradine (Procorala) Lowers Cardiovascular Death And Hospitalization Risk For Heart Failure Patients

August 30, 2010 – 1:22 am

Ivabradine (Procorala), a heart-rate-lowering medication, considerably lowers cardiovascular death and hospitalization risk when added to standard treatment in patients suffering from heart failure and a high heart rate (pulse rate), an Article reveals in the medical journal The Lancet. Details of a clinical trial were presented at the European Society of Cardiology Annual Congress 2010, Stockholm, Sweden…




Find more info about Ivabradine (Procorala) Lowers Cardiovascular Death And Hospitalization Risk For Heart Failure Patients photos videos pictures. read more




Related Info :

Tags: , , , , , , , , , , , , , , , , , , , , , , , , ,

Sorry, comments for this entry are closed at this time.